Xiang Yang Lu
Algemeen Directeur bij LAEKNA, INC.
Vermogen: 43 M $ op 31-05-2024
Actieve functies van Xiang Yang Lu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LAEKNA, INC. | Algemeen Directeur | 29-07-2016 | - |
| Voorzitter | 29-07-2016 | - | |
| Oprichter | 29-07-2016 | - | |
Laekna Therapeutics (Shanghai) Co., Ltd.
 Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | - | - |
| Algemeen Directeur | 01-12-2016 | - | |
| Oprichter | 01-12-2016 | - | |
| Laekna Ltd. | Directeur/Bestuurslid | - | - |
Loopbaan van Xiang Yang Lu
Eerdere bekende functies van Xiang Yang Lu
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| China Novartis Institutes for BioMedical Research Co., Ltd. | Directeur/Bestuurslid | 01-09-2003 | 01-03-2016 |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | 01-09-2003 | 01-03-2016 |
| Frontline Bioventures | Corporate Officer/Principal | 01-01-2016 | - |
Opleiding van Xiang Yang Lu
| Nankai University | Undergraduate Degree |
| The University of North Carolina at Chapel Hill | Doctorate Degree |
Statistieken
Internationaal
| China | 6 |
| Verenigde Staten | 3 |
| Hongkong | 2 |
Operationeel
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LAEKNA, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Laekna Therapeutics (Shanghai) Co., Ltd.
Laekna Therapeutics (Shanghai) Co., Ltd. Pharmaceuticals: MajorHealth Technology Laekna Therapeutics (Shanghai) Co. Ltd. focuses on drug discovery and development. The company was founded by Chris Xiangyang Lu in December 2016 and is headquartered in Shanghai, China. | Health Technology |
| Frontline Bioventures | Finance |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
| Laekna Ltd. | |
| China Novartis Institutes for BioMedical Research Co., Ltd. |
- Beurs
- Insiders
- Xiang Yang Lu
- Ervaring
